Annual CFI
-$93.00 K
+$175.00 K+65.30%
December 31, 2023
Summary
- As of February 7, 2025, EVAX annual cash flow from investing activities is -$93.00 thousand, with the most recent change of +$175.00 thousand (+65.30%) on December 31, 2023.
- During the last 3 years, EVAX annual CFI has risen by +$300.00 thousand (+76.34%).
- EVAX annual CFI is now -1650.00% below its all-time high of $6000.00, reached on December 31, 2018.
Performance
EVAX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
N/A
September 1, 2024
Summary
- EVAX quarterly cash flow from investing activities is not available.
Performance
EVAX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
September 1, 2024
Summary
- EVAX TTM cash flow from investing activities is not available.
Performance
EVAX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
EVAX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +65.3% | - | - |
| 3 y3 years | +76.3% | - | - |
| 5 y5 years | -1650.0% | - | - |
EVAX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +93.0% | ||||
| 5 y | 5-year | -36.8% | +93.0% | ||||
| alltime | all time | -1650.0% | +93.0% |
Evaxion Biotech A/S Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$93.00 K(-65.3%) | - | - |
| Dec 2022 | -$268.00 K(-79.8%) | - | - |
| Jun 2022 | - | -$77.00 K(-51.6%) | -$744.00 K(-36.0%) |
| Mar 2022 | - | -$159.00 K(-10.2%) | -$1.16 M(-12.6%) |
| Dec 2021 | -$1.33 M | -$177.00 K(-46.5%) | -$1.33 M(-6.0%) |
| Sep 2021 | - | -$331.00 K(-33.1%) | -$1.42 M(+29.9%) |
| Jun 2021 | - | -$495.00 K(+51.4%) | -$1.09 M(+70.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$327.00 K(+24.8%) | -$639.00 K(+62.6%) |
| Dec 2020 | -$393.00 K(+477.9%) | -$262.00 K(+5140.0%) | -$393.00 K(+200.0%) |
| Sep 2020 | - | -$5000.00(-88.9%) | -$131.00 K(+4.0%) |
| Jun 2020 | - | -$45.00 K(-44.4%) | -$126.00 K(+55.6%) |
| Mar 2020 | - | -$81.00 K | -$81.00 K |
| Dec 2019 | -$68.00 K(-1233.3%) | - | - |
| Dec 2018 | $6000.00 | - | - |
FAQ
- What is Evaxion Biotech A/S annual cash flow from investing activities?
- What is the all time high annual CFI for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S annual CFI year-on-year change?
- What is the all time high quarterly CFI for Evaxion Biotech A/S?
- What is the all time high TTM CFI for Evaxion Biotech A/S?
What is Evaxion Biotech A/S annual cash flow from investing activities?
The current annual CFI of EVAX is -$93.00 K
What is the all time high annual CFI for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high annual cash flow from investing activities is $6000.00
What is Evaxion Biotech A/S annual CFI year-on-year change?
Over the past year, EVAX annual cash flow from investing activities has changed by +$175.00 K (+65.30%)
What is the all time high quarterly CFI for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high quarterly cash flow from investing activities is -$5000.00
What is the all time high TTM CFI for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high TTM cash flow from investing activities is -$81.00 K